Paladin Wealth’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
FFM
PCM
OIAM
GI
BIAS
EOJOAM
CNB
Paladin Wealth's DXCM Position: Q2 2026 in Review
Paladin Wealth increased its DexCom (DXCM) stake by 17% in Q2 2026, buying an estimated $92.3K and bringing the position to 9,338 shares worth $629K. The position accounts for 0.37% of the portfolio, ranked #82.
Paladin Wealth first reported a position in DXCM in Q3 2024 and has held it in 8 quarters since. The position peaked at $751K in Q2 2025. 115 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Paladin Wealth held 9,338 shares of DexCom worth $629K as of Q2 2026.
- Paladin Wealth bought 1,386 DexCom shares in Q2 2026, an estimated $92.3K.
- DexCom made up 0.37% of Paladin Wealth's portfolio in Q2 2026, its #82 holding.
- Paladin Wealth first reported a position in DexCom in Q3 2024 and has held it in 8 quarters since.
- Paladin Wealth's DexCom position peaked at $751K in Q2 2025.
- 115 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Paladin Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.